Suppr超能文献

氯化镁通过钙敏感受体抑制血管平滑肌细胞的成骨/软骨形成转化

Inhibition of osteo/chondrogenic transformation of vascular smooth muscle cells by MgCl2 via calcium-sensing receptor.

作者信息

Alesutan Ioana, Tuffaha Rashad, Auer Tilman, Feger Martina, Pieske Burkert, Lang Florian, Voelkl Jakob

机构信息

aDepartment of Cardiology, Vascular Medicine and Physiology, University of Tübingen, Tübingen bDepartment of Internal Medicine and Cardiology, Charité University Medicine, Campus Virchow-Klinikum cBerlin Institute of Health (BIH) dDepartment of Internal Medicine and Cardiology, German Heart Center Berlin (DHZB), Berlin, Germany.

出版信息

J Hypertens. 2017 Mar;35(3):523-532. doi: 10.1097/HJH.0000000000001202.

Abstract

OBJECTIVES

The progression of vascular calcification, an active process promoted by osteo/chondrogenic transformation of vascular smooth muscle cells (VSMCs) is attenuated by activation of the calcium-sensing receptor (CASR). Recent in-vitro studies revealed that vascular calcification could be blunted by Mg, but the underlying mechanisms remained elusive. The present study explored whether the effects of MgCl2 on vascular calcification involve the CASR.

METHODS

Experiments were performed in primary human aortic smooth muscle cells (HAoSMCs) and in the mouse vascular calcification model of vitamin D3 overload.

RESULTS

Phosphate-induced calcium deposition and mRNA expression of the osteogenic markers msh homeobox 2 (MSX2), CBFA1 (core-binding factor α 1), and ALPL (tissue-nonspecific alkaline phosphatase) in HAoSMCs were blunted by additional treatment with MgCl2. MgCl2 upregulated CASR mRNA expression in HAoSMCs in a dose-dependent manner. Furthermore, the inhibitory effects of MgCl2 on phosphate-induced calcium deposition and osteogenic markers mRNA expression were mimicked by the CASR agonist GdCl3 and reversed by additional treatment with the CASR antagonist NPS-2143 or by silencing of the CASR gene in HAoSMCs. MgCl2 also blunted the osteogenic transformation of VSMCs induced by hydroxyapatite particles. High-dosed cholecalciferol treatment induced vascular calcification and upregulated aortic osteogenic markers Msx2, Cbfa1 and Alpl and collagen type I (Col1a1), collagen type III (Col3a1) and fibronectin (Fbn) mRNA expression in mice, effects reduced by additional treatment with MgCl2. These effects were paralleled by increased aortic Casr mRNA expression in cholecalciferol-treated mice, which was further augmented by MgCl2.

CONCLUSION

The protective effects of MgCl2 on osteo/chondrogenic transformation of VSMCs and vascular calcification involve regulation of CASR and CASR-dependent signaling.

摘要

目的

血管钙化是一个由血管平滑肌细胞(VSMCs)向成骨/软骨细胞转化所推动的活跃过程,钙敏感受体(CASR)的激活可使其进程减缓。近期的体外研究表明镁可抑制血管钙化,但其潜在机制仍不清楚。本研究探讨了氯化镁对血管钙化的影响是否涉及CASR。

方法

实验在原代人主动脉平滑肌细胞(HAoSMCs)和维生素D3过载小鼠血管钙化模型中进行。

结果

在HAoSMCs中,额外添加氯化镁可抑制磷酸盐诱导的钙沉积以及成骨标志物肌节同源盒2(MSX2)、核心结合因子α1(CBFA1)和组织非特异性碱性磷酸酶(ALPL)的mRNA表达。氯化镁以剂量依赖的方式上调HAoSMCs中CASR的mRNA表达。此外,CASR激动剂GdCl3可模拟氯化镁对磷酸盐诱导的钙沉积和成骨标志物mRNA表达的抑制作用,而在HAoSMCs中额外添加CASR拮抗剂NPS - 2143或沉默CASR基因可逆转这种抑制作用。氯化镁还可抑制羟基磷灰石颗粒诱导的VSMCs成骨转化。高剂量胆钙化醇处理可诱导小鼠血管钙化,并上调主动脉成骨标志物Msx2、Cbfa1和Alpl以及I型胶原(Col1a1)、III型胶原(Col3a1)和纤连蛋白(Fbn)的mRNA表达,而额外添加氯化镁可减轻这些影响。胆钙化醇处理的小鼠主动脉中Casr mRNA表达增加,而氯化镁可进一步增强这种增加。

结论

氯化镁对VSMCs成骨/软骨细胞转化和血管钙化的保护作用涉及对CASR及其依赖信号通路的调节。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验